A Takeda Pharmaceutical Co. Ltd. Manager Asks the Supreme Court to Review a Whistleblower Ruling

Published: Aug 15, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Will a recent appeals court ruling restrict the ability of whistleblowers to file lawsuits that allege drugmakers duped federal healthcare programs into paying for medicines? This is the contention made by Noah Nathan, a sales manager at Takeda Pharmaceuticals, who claims the drugmaker defrauded Medicare by falsely marketing higher doses of its Kapidex treatment for gastroesophageal reflux disease, or GERD, than what was approved by the FDA. So far, Nathan has lost two rounds in court, but now hopes the US Supreme Court will review his case.

Help employers find you! Check out all the jobs and post your resume.

Back to news